MIR5192

Across TCGA pan-cancer cohorts, MIR5192 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR5192’s most consistent transcriptional readouts.

The strongest signal is observed in cholangiocarcinoma (CHOL), where MIR5192 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR5192 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

CHOL, BRCA, and THCA are the cancer types where MIR5192 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR5192 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CHOL	All	II,III,IV	+0.835	<.001	4	view →
BRCA	Female	All	+0.189	.023	2	view →
THCA	All	All	−0.205	.010	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR5192–CHOL

Open the CHOL breakdown →